title: The risk-benefit ratio of the proposed DSM-5 attenuated psychosis syndrome.
authors.forename: Scott W
authors.initials: SW
authors.lastname: Woods
authors.forename: Thomas H
authors.initials: TH
authors.lastname: McGlashan
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D006801:Humans; D012559:Schizophrenia / Q000175:diagnosis* / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012569:Schizotypal Personality Disorder / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents